Rights and permissions
About this article
Cite this article
Change antihypertensive drug class, increase acquisition costs. Pharmacoecon. Outcomes News 50, 5 (1996). https://doi.org/10.1007/BF03269817
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269817